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SUMMARY Brachyspira pilosicoli is a slow-growing anaerobic spirochete that colo-
nizes the large intestine. Colonization occurs commonly in pigs and adult chickens,
causing colitis/typhlitis, diarrhea, poor growth rates, and reduced production. Coloni-
zation of humans also is common in some populations (individuals living in village
and peri-urban settings in developing countries, recent immigrants from developing
countries, homosexual males, and HIV-positive patients), but the spirochete rarely is
investigated as a potential human enteric pathogen. In part this is due to its slow
growth and specialized growth requirements, meaning that it is not detectable in
human fecal samples using routine diagnostic methods. Nevertheless, it has been
identified histologically attached to the colon and rectum in patients with conditions
such as chronic diarrhea, rectal bleeding, and/or nonspecific abdominal discomfort,
and one survey of Australian Aboriginal children showed that colonization was sig-
nificantly associated with failure to thrive. B. pilosicoli has been detected in the
bloodstream of elderly patients or individuals with chronic conditions such as alco-
holism and malignancies. This review describes the spirochete and associated dis-
eases. It aims to encourage clinicians and clinical microbiologists to consider B. pi-
losicoli in their differential diagnoses and to develop and use appropriate diagnostic
protocols to identify the spirochete in clinical specimens.
KEYWORDS spirochete, Brachyspira, colitis, zoonosis, animals, epidemiology,
diagnosis, control
INTRODUCTION
This review summarizes the characteristics of the anaerobic intestinal spirocheteBrachyspira pilosicoli, the diseases that it causes in animals and in humans, its
natural history, and methods for diagnosis and control. The review aims to increase
understanding of this organism, particularly by medical scientists who may not have
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encountered it. Descriptions of the infections in animals provide comparative data that
assist in understanding the spirochete’s ecology and provide insights into its patho-
genicity.
Although B. pilosicoli is recognized as being a pathogen in many mammalian and
avian species, there is still uncertainty about the pathogenic importance of B. pilosicoli
in humans, and its potential role as a human pathogen is rarely considered. This lack of
attention occurs despite the high prevalence of colonization in certain human popu-
lation groups, as revealed in targeted surveys. Infections with B. pilosicoli present
numerous diagnostic difficulties, as the spirochete is anaerobic, grows slowly without
forming colonies, and requires selective growth media. Although appropriate culture
conditions and molecular-based methodology such as PCR assays are used to detect
Brachyspira species in specialized veterinary diagnostic laboratories receiving samples
from pigs, these methods are not routinely used in laboratories primarily handling
samples from poultry or from other species of animals. Likewise, they are not available
for use in clinical diagnostic laboratories that examine specimens from humans, except
for a few laboratories that undertake special diagnostic investigations.
HISTORY AND NOMENCLATURE
Records from the earliest days of microscopy describe the presence of spirochetes
in feces obtained from humans and animals. Some of these spirochetes undoubtedly
were members of one or another of the nine officially recognized Brachyspira species.
Key features of these species are presented in Table 1.
The first clear description of the spirochete that is now known as Brachyspira
pilosicoli was made in the United Kingdom in 1980 (1). Weakly hemolytic isolate
P43/6/78 (now the type strain of B. pilosicoli) was recovered from a fecal sample from
a pig on a farm where weaned and growing pigs exhibited colitis and mucoid diarrhea.
Pigs that subsequently were experimentally challenged orally with P43/6/78 developed
colitis and diarrhea, and in one animal, large numbers of spirochete cells were found
attached by one cell end to the luminal surface of colonocytes, giving the appearance
of a “false brush border.” The condition was called intestinal spirochetosis (IS) to
differentiate it from another, more severe colitis in pigs called swine dysentery (SD). The
name “intestinal spirochetosis” previously had been used for a condition in humans
with chronic diarrhea and other abdominal complaints, where spirochetes also were
observed attached as a “false brush border” to the colorectal epithelium (2). The
condition in humans was defined only on the basis of observing this characteristic
end-on attachment of spirochetes in histological sections of the colon and/or rectum,
as it had not proved possible to isolate and identify the associated microorganisms in
the late 1960s.
In 1982 a small anaerobic spirochete named Brachyspira aalborgi was isolated from
a colonic biopsy sample in a histologically identified human case of IS (human intestinal
TABLE 1 Names and characteristics of the nine officially named Brachyspira species
Species Hemolysis Main host species Diseasea Previous names
B. pilosicoli Weak Pigs, chickens, and other species,
including humans
Intestinal spirochetosis (AIS, PIS, HIS) “Anquilina coli,” Serpulina pilosicoli
B. aalborgi Weak Humans and possibly other
nonhuman primates
Intestinal spirochetosis (HIS) NAb
B. hyodysenteriae Strong Pigs Swine dysentery Treponema hyodysenteriae, Serpulina
hyodysenteriae
B. hampsonii Strong Pigs, waterbirds Swine dysentery NA
B. suanatina Strong Ducks, pigs Swine dysentery NA
B. intermedia Weak Chickens, pigs AIS Serpulina intermedia
B. innocens Weak Pigs, chickens, rats Not recorded Treponema innocens, Serpulina innocens
B. murdochii Weak Pigs, chickens, rats Mild colitis in pigs Serpulina murdochii
B. alvinipulli Weak Chickens AIS Serpulina alvinipulli
aAIS, avian intestinal spirochetosis; PIS, porcine intestinal spirochetosis; HIS, human intestinal spirochetosis.
bNA, not applicable.
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spirochetosis [HIS]) (3). This spirochete grew even more slowly than the porcine
pathogen P43/6/78, taking more than 2 weeks to appear on the plates. To date, B.
aalborgi has been detected in human beings and possibly in some species of nonhu-
man primates (4). For a number of years following this isolation, it was assumed that B.
aalborgi was the (sole) etiological agent causing histologically identified IS in humans,
even though B. pilosicoli had been found to cause a similar end-on attachment in
colonized pigs (1).
Around the same time, in the early 1980s, and using methods similar to those used
to cultivate intestinal spirochetes from pigs, unidentified spirochetes that were later
recognized as B. pilosicoli were being isolated from the feces of humans with different
nonspecific intestinal complaints (5–11), as well as from patients where HIS was
histologically identified (12–15).
Also in the 1980s, and using the methods described for isolating porcine intestinal
spirochetes, anaerobic spirochetes started to be identified and isolated from the feces
and ceca of adult chickens with various clinical signs, including diarrhea and delays to
the start of egg production (15–17). The condition was called avian intestinal spiro-
chetosis (AIS). In some cases, spirochetes were observed forming a “false brush border”
attached to the cecal epithelium (18), and this type of spirochete is now known to have
been B. pilosicoli (19). The other two pathogenic species that may cause forms of AIS,
Brachyspira intermedia and Brachyspira alvinipulli, do not appear to attach to the cecal
epithelium in this characteristic way.
Work undertaken in the early to mid-1990s, using mainly multilocus enzyme elec-
trophoresis (20–23) but also DNA-DNA hybridization, 16S rRNA gene sequencing, and
biochemical testing (24–26), demonstrated that spirochetes resembling P43/6/78 that
had been isolated from pigs, human beings, and poultry all belonged to a distinct new
species of intestinal spirochete that is now known as B. pilosicoli (27). At that time this
species was referred to as “Anguillina coli” (21, 22) or “group IV weakly hemolytic
intestinal spirochetes” (25), before being officially named Serpulina pilosicoli (28).
Subsequently, all species from the genus Serpulina were reassigned to the genus
Brachyspira, and S. pilosicoli was renamed Brachyspira pilosicoli (27). Around the same
time, B. pilosicoli was demonstrated colonizing wild ducks (29), domesticated turkeys
(30), pheasants (31), rodents (32), dogs (33–35), young horses with chronic diarrhea
(36), and a number of species of other animals and birds (37).
To date, IS in pigs (porcine intestinal spirochetosis [PIS]) has been associated only
with B. pilosicoli. On the other hand, spirochete species other than B. pilosicoli some-
times may be involved in HIS and AIS. HIS generally is diagnosed on the appearance of
attached spirochetes in histological sections from colorectal biopsy specimens, as most
medical microbiology laboratories do not routinely use methods that are suitable for
isolating and identifying these spirochetes. It is desirable that in the future appropriate
diagnostic microbiological methods be used for identification of infections with B.
pilosicoli in humans and poultry, as occurs with pigs. Furthermore, in cases where B.
pilosicoli is identified as the etiological agent in HIS and AIS, it would aid clarity if the
conditions were reported as “Brachyspira pilosicoli-associated HIS” and “Brachyspira
pilosicoli-associated AIS,” respectively.
DESCRIPTION OF BRACHYSPIRA PILOSICOLI
The B. pilosicoli type strain is P43/6/78T (ATCC 51139T), and it was originally isolated
from a pig with colitis and diarrhea (1). B. pilosicoli strains grow in an anaerobic
environment at temperatures between 37 and 42°C. They are weakly beta-hemolytic
on Trypticase soy blood agar, usually hydrolyze hippurate, and utilize D-cellobiose,
D-fructose, L-fucose, D-galactose, N-acetyl-D-glucosamine, D-glucosamine, D-glucose,
maltose, D-mannose, pyruvate, sucrose, D-trehalose, and D-ribose as growth substrates.
Metabolic products generated include acetate, butyrate, ethanol, hydrogen, and carbon
dioxide. The spirochete consumes substrate amounts of oxygen and has GC contents
in the range 27.4 to 27.9 mol%. Cells have tapered ends and are 4 to 10 m long and
0.2 to 0.3 m wide. Each spirochete cell has 8 or 10 periplasmic flagella, with 4 or 5
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flagella attached through insertion discs at each cell end. In common with other
spirochete species, these two sets of periplasmic flagella cross over near the midpoint
of the cell (26).
Essential Cultural Characteristics
Brachyspira pilosicoli is a slow-growing anaerobe, typically taking 3 to 5 days before
forming a thin flat film of growth surrounded by a zone of weak hemolysis on the
surface of blood agar. The spirochete stains poorly with Gram’s stain and is best
observed with Warthin-Starry silver staining or by resuspending surface growth and
observing the motile, flexuous, thin spiral- or comma-shaped cells under a phase-
contrast or dark-field microscope (Fig. 1). The slow in vitro growth of B. pilosicoli means
that it can be isolated only by using specialized selective media that inhibit overgrowth
by other anaerobic members of the intestinal microbiota, and these plates are not
routinely available commercially. Spirochetemia caused by B. pilosicoli can be detected
using some manual blood culture systems, with an incubation period of up to 10 days,
followed by subculture. Detection in the automated Bactec blood culture system with
Anaerobic/F medium can take up to 15 days of incubation. The spirochete may not
grow or signal in other blood culture systems (38).
Strain Diversity and Population Structure
The strain diversity and population structure of B. pilosicoli have been analyzed
using a variety of methods, including multilocus enzyme electrophoresis (20–23),
pulsed-field gel electrophoresis (PFGE) (39), multilocus sequence typing (40), and
variable-number tandem repeat analysis (41). Each of these methods has been applied
to large collections of isolates recovered from different species and geographic origins.
In each case the isolates in the collections were shown to be highly diverse, and the
population structure was deduced to be recombinant (i.e., undergoing significant
genetic recombination), as assessed by calculating the index of association (42). This is
in contrast to the clonal population structure of Brachyspira hyodysenteriae, where
recombination occurs less frequently.
Genomic Features
Analysis of the whole genome sequence of B. pilosicoli strain 95/1000, recovered
from a pig, showed that it had a single circular chromosome of approximately 2.59 Mb
(43). Unlike the case for the genome of B. hyodysenteriae strain WA1 (44), no extrach-
romosomal elements were found, but a previously unreported bacteriophage sequence
was identified. To date, this is the second smallest genome of the different Brachyspira
species to be reported, with only B. aalborgi 513T being marginally smaller. Genes for
a bacteriophage-like gene transfer agent (GTA) were identified in strain 95/1000,
confirming previous findings (45). Among other features, genes predicted to be in-
volved with protection from oxidative stress were identified, including those encoding
FIG 1 Appearance of motile, flexuous, thin, spiral-shaped cells of B. pilosicoli as observed under a
phase-contrast microscope.
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a glycine reductase complex that permits the use of glycine at the same time as
protecting from oxidative stress, for aconitase and related enzymes in the incomplete
citric acid cycle that allow synthesis of glutamate and allow the cycle to function during
oxidative stress, and for NADH oxidase, an enzyme that consumes oxygen and is known
to be present in all Brachyspira species (43). These enzyme activities are thought to help
B. pilosicoli survive exposure to oxygen in the colon and in the external environment.
In a separate study, a comparative analysis of the genome of B. pilosicoli 95/1000
and the genome of B. hyodysenteriae WA1 identified a highly conserved 26-kb region
shared by the two spirochete strains (46). Furthermore, the genomes of the enteric
species Enterococcus faecalis and Escherichia coli contained substantial conservation of
gene clusters across this same region, suggesting that it has been shared between
these four species through horizontal gene transfer in the intestinal environment. This
finding supports the observation that predicted proteins of B. hyodysenteriae WA1 had
more similarities to proteins from E. coli and Clostridium species than they did to
proteins from other spirochete species (46). A large number of the predicted proteins
were associated with transport and metabolism, and again these genes may have been
shared in the milieu of the large intestine through horizontal gene transfer.
More recently Mappley et al. (47) reported a comparative analysis of the genomes
of B. pilosicoli strains 95/1000, B2904, and WesB, which were isolated from a pig, a
chicken, and a human, respectively. The study included an analysis of phenotypic
properties of the strains using a Biolog phenotype microarray. The sizes of the genomes
of the three strains varied considerably (from approximately 2.59 to 2.89 Mb), and they
showed major genome rearrangements that coincided mainly with the locations of
mobile genetic elements. B. pilosicoli has been inferred to have a greater recombination
rate than other Brachyspira species, apart from B. aalborgi (48), and of the three strains
analyzed, WesB in particular appears to have undergone many recombination events.
Hampson and Wang (48) speculated that the movement of large genome islands forms
four potential pathways for genomic rearrangements in B. pilosicoli, while the activity
of GTAs also may contribute to smaller-scale genome rearrangements (45, 49). Differ-
ences in the presence of some genes were identified between the strains, including
those encoding glycine reductase complex components and transposases. Despite the
small genome size range, B. pilosicoli strains encode more proteins than other
Brachyspira species, possibly because of having a greater number of gene duplications
and greater homogeneity than other Brachyspira species (48). The three strains of B.
pilosicoli shared 2,132 genes, with 112 to 256 genes being unique to each strain (47).
Different pairs of strains shared another 236, 38, and 19 genes, respectively. The three
strains had similar distributions of features in the Cluster of Orthologous Genes
database. Screening of the strains for utilization of 178 different carbon compounds
demonstrated that their metabolic capacity was highly conserved. Differences were
found only in seven of the carbon sources examined (D-mannose, D-glucuronic acid,
D-mannitol, glucoronamide, -D-allose, -methyl-D-glucuronic acid, and L-sorbitol), and
these correlated with observed genotypic differences between the strains.
Subsequently Lin et al. (50) described the genome of strain P43/6/78T, which was
about 2.56 Mb and was most similar to the genome of strain 95/1000, also isolated from
a pig. Most of the unique genes in P43/6/78T encoded hypothetical proteins, and some
were considered to be potentially involved in O-antigen variation.
Cell Surface Properties
The B. pilosicoli outer envelope contains lipooligosaccharide (LOS) rather than
lipopolysaccharide (LPS), and this material has been shown to be serologically heter-
ogeneous among different strains (51). A number of specific outer membrane proteins
and lipoproteins of B. pilosicoli have been described (52), but more work is needed to
define their potential role in disease, including whether or not they may be involved in
important functions such as attachment and/or in generating protective immunity.
Recently, exposed proteins on the cell surface and peptides and proteins in extracel-
lular growth medium were characterized using a high-resolution Orbitrap instrument
Hampson Clinical Microbiology Reviews
January 2018 Volume 31 Issue 1 e00087-17 cmr.asm.org 6
 on D
ecem























with multiple liquid chromatography-tandem mass spectrometry (LC-MS/MS) runs (53).
More than 29,000 peptides were identified, with 1,38 proteins being unique to B.
pilosicoli. The levels of expression of these proteins varied considerably, and this
emphasizes the need to consider gene expression when the biological significance of
such proteins is investigated.
DISEASES CAUSED BY BRACHYSPIRA PILOSICOLI
Disease in Pigs
Background and occurrence. The disease caused by infection with B. pilosicoli in
pigs is called porcine intestinal spirochetosis (PIS) or porcine colonic spirochetosis (54).
It is distinct from the more severe disease called swine dysentery (SD) resulting from
infection with one or another related strongly hemolytic spirochetes, including
Brachyspira hyodysenteriae, Brachyspira hampsonii, or Brachyspira suanatina (54). In SD,
severe mucohemorrhagic colitis occurs, with bloody mucoid diarrhea and substantial
loss of production. Although SD was recognized in the 1920s, the spirochetal etiology
was not demonstrated for another 50 years (55, 56). Application of the methodology
developed to isolate this anaerobic spirochete ultimately resulted in the discovery and
description of the weakly hemolytic B. pilosicoli in 1980 (1).
Subclinical colonization of pigs with B. pilosicoli occurs commonly on some farms.
On other farms, the spirochete may be isolated from diseased pigs alone or as part of
a mixed infection with other enteric pathogens. Clinical cases of PIS usually occur in
pigs soon after they are weaned, in recently mixed growing pigs that have been
transferred to a new diet, or in finishing pigs at the last stage of production, after all
antimicrobials are withdrawn from the diet. Changes of diet or other causes of
disruption to the colonic microbiota, such as the use or cessation of use of oral
antimicrobials, may predispose to spirochete proliferation and disease. PIS can affect
groups of pigs of the same age or pigs of mixed ages.
Clinical signs. Brachyspira pilosicoli is shed in the feces within 2 to 7 days of
experimental inoculation, although the incubation period may extend up to 20 days.
The first clinical signs usually are hollowing of the flanks and development of watery to
mucoid diarrhea. The fecal consistency often changes to resemble wet cement or
porridge, and it may glisten when mucus is present. Diarrhea may be green or brown
and occasionally contains plugs of mucus and sometimes flecks of blood. Diarrhea
usually lasts 2 to 14 days, although it may recur.
Affected pigs are unthrifty, have fecal staining of the perineal area and a
hunched-up appearance, and sometimes are febrile, but they usually continue to eat.
Pigs with recurrent diarrhea may show significant loss of body condition, poor feed
conversion rates, and delays in reaching market weight (57).
Disease in Chickens
Background and occurrence. Young meat-producing chickens (broilers) are suscep-
tible to experimental infection with Brachyspira species, including B. pilosicoli (58–62),
but under farm conditions they rarely suffer from AIS because they are slaughtered at
around 6 weeks of age, before they are likely to have had significant exposure to
Brachyspira species. On the other hand, AIS caused by infection with B. pilosicoli (and
other Brachyspira species) commonly occurs in adult chickens laying table eggs and in
breeding hens producing meat chickens (broiler breeders) (63–70). Infection is partic-
ularly common in chickens under free-range conditions (71, 72). Occasionally infection
is reported in other poultry species, such as turkeys (30). Colonization and disease have
been reported in many regions of the world (73–77). Infections can vary from being
asymptomatic to severe, with increased mortality rates. Most commonly, infections are
mild or moderate and generally are characterized by diarrhea with feces that are
caramel in color and are frothy as a result of increased gas production.
Clinical signs. The most economically significant outcomes of AIS are delayed onset
and/or loss of egg production and an increase in fecal water content that results in “wet
litter” (wet bedding material). In one early study, natural infection of two layer flocks
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with B. pilosicoli was associated with a 5% reduction in egg production, diarrhea in up
to 25% of chickens, wet droppings, feces smeared on the feathers around the cloaca
(“pasty vents”), lethargy, and depression (18). Subsequent observations of field cases
have found that cases of AIS (not all of which necessarily were caused by or solely by
B. pilosicoli) may result in increases in fecal water content, a lower growth rate, a delay
in the onset of egg laying, and a decrease in numbers and quality of eggs (78–81). The
shells of eggs from infected chickens may be contaminated with feces, and this limits
opportunities for their sale as table eggs. The eggs also may be smaller, be lighter, have
paler yolks, and have poorer shell quality than those from uninfected chickens. The
progeny of chickens with AIS may be weak and show depressed weight gain, despite
not being colonized (79, 82).
Experimental infection of adult breeder chickens with an avian B. pilosicoli strain
resulted in a temporary increase in content of fecal water, fecal staining of eggshells,
and a significant reduction in total production of eggs (79). The ceca of the infected
birds were gassy, and the contents were frothy, fluid, and pale, but no gross or
histological lesions were detected in the mucosa. Spirochetes were isolated but they
were not found attached to the cecal epithelium. In another experiment, commercial-
egg-laying chickens were experimentally challenged with one or the other of two
strains of B. pilosicoli isolated from chickens. Approximately 80% of the chickens
became colonized, and they had increased fecal water content and a reduction in
weight gain, and the onset of egg laying was delayed (83).
Disease in Humans
Background and occurrence. Relatively few studies have specifically investigated B.
pilosicoli infections in humans. Most studies on “intestinal spirochetosis” have involved
observation of colorectal biopsy specimens that show spirochetes attached to the
epithelial surface, to form a “false brush border” (Fig. 2). Furthermore, in many such
cases the species of spirochete present has not been identified. Publications have
included case reports, analysis of archived histological samples, and reviews of the
literature. Other sorts of studies have involved targeted examination for carriage of B.
pilosicoli by analyzing fecal samples collected from individuals with different health
statuses and from different regions. Frequently these studies have sought to determine
risk factors for colonization and to look for associations with disease.
Clinical signs. The majority of patients who have been described with histologically
defined HIS have been from developed westernized countries, although rectal biopsy
specimens showing false brush borders of spirochetes also have been recorded in rural
patients from southern India (84) and from Brazil (85). Individuals with biopsy samples
showing evidence of HIS may have one or another of a range of nonspecific symptoms
attributable to an underlying chronic intestinal complaint for which other potential
FIG 2 Appearance of a “false brush border” of Brachyspira pilosicoli cells attached by one cell end to the
luminal surface of human colonic enterocytes in a patient diagnosed with HIS.
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etiological factors have been excluded. Examples include abdominal pain, change in
bowel habits, pseudoappendicitis, irritable bowel, diverticulitis, chronic nonwatery
diarrhea, and rectal bleeding (86–91). On the other hand, HIS also has been observed
as an incidental finding in biopsy specimens taken for other reasons; in such cases, and
particularly where specific pathological changes are not found, the spirochetes appear
to have a commensal relationship with the host (92). It has been difficult to reconcile
these different findings, and particularly so as the identity of the spirochete species
involved in different cases is rarely determined. Several reviews have concluded that
clinical signs are more common where extensive spirochetal colonization occurs, with
or without end-on attachment being observed, but particularly with spirochetal inva-
sion occurring beyond the surface epithelium (93, 94). Clinical signs also appear to be
more common and severe in colonized children, in patients who are infected with
human immunodeficiency virus (HIV-positive [HIV] patients), and in homosexual
males than they are in other individuals (86, 87, 94).
Only one human experimental infection has been reported, where a volunteer (the
author) drank cultures of B. pilosicoli strain WesB isolated from an Australian Aboriginal
child with diarrhea (29). Examination of fecal samples demonstrated that the volunteer
had become heavily colonized with the B. pilosicoli strain; he developed abdominal
pain, bloating, and headaches, but diarrhea did not occur and B. pilosicoli was not
isolated from the bloodstream. Treatment with oral metronidazole promptly removed
the spirochetes from the feces, and the clinical symptoms ceased. Colonic biopsy
specimens were not obtained. The results of this experiment are consistent with B.
pilosicoli being able to cause nonspecific abdominal complaints in humans.
A number of patients with a B. pilosicoli spirochetemia have been described (95–
101). In all cases these individuals have been chronically ill and/or immunocompro-
mised, and the spirochetemia is likely to have been secondary to the immunosuppres-
sion. It remains unclear to what extent the spirochetemia may contribute to clinical
signs in these patients, although some have shown multiorgan failure. Spirochetemia
with B. pilosicoli is probably uncommon, since a study failed to identify any cases
following examination of 1,063 blood samples from patients considered to be poten-
tially at risk of being colonized (102).
PATHOGENESIS
The molecular mechanisms by which B. pilosicoli causes disease are not well
understood, even though natural animal models are available. An early study looking
for virulence-associated genes demonstrated that the spirochete lacks the attachment
and invasion determinants found in the enterobacteria (103). Despite the recent
availability of genome sequences, so far only a few B. pilosicoli attributes that might
contribute to disease have been identified. Progress remains hampered by a lack of
means for genetic manipulation of these bacteria, and without these tools, it is difficult
to be able to determine the functional significance of individual genes or groups of
genes whose products may be involved in the disease process.
Infection is thought to be predominantly by the direct fecal-oral route, with expo-
sure to fecally contaminated water being postulated as a potentially important route of
transmission (29, 104, 105). It is assumed that the spirochete passes through the
stomach and small intestine protected within boluses of food or other organic matter,
although it has been suggested that waterbirds also may acquire cecal infection from
contaminated water in ponds by retroperistalsis of water up through the cloaca (70). B.
pilosicoli cells show a chemoattraction to mucin solutions (106), and they produce
enzymes, including the sialidase family-like proteins, that hydrolyze the mucus inner
layer and may assist in penetration of the mucus overlying the colonic mucosa (43, 107,
108). B. pilosicoli is actively motile, with its periplasmic flagella generating a typical
spirochetal “corkscrew-like” twisting motility that drives the spirochete forward, allow-
ing it to penetrate the mucus. Swimming speeds increase as the viscosity of the
medium increases, including at mucus concentrations that are equivalent to those
found in the colon (106, 109). Different strains may vary both in their motility and in
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their chemotactic responses to mucin (106), and this could influence their relative
colonization potential. Recently it has been demonstrated that expression profiles for
different mucins may change in human patients with HIS who have different categories
of lesions. It is not clear if these changes in mucin expression are driven by the
spirochetes themselves or by associated alterations in other components of the intes-
tinal microbiota (110). Given the important interactions between the spirochetes and
mucus, these changes may be significant in the colonization process.
Once the spirochetes penetrate through the mucus overlying the enterocytes, one
cell end attaches to the luminal surface of these cells (59, 111) (Fig. 3). Attachment
occurs to mature apical enterocytes between crypt units but not to immature cells
deeper in the crypts (112). B. pilosicoli surface lipoproteins may be involved in facili-
tating this attachment by undergoing protein-protein interactions with specific recep-
tors on the cell surface (52). If a sufficient number of cells become attached, this gives
the appearance of a “false brush border.” Where massive colonization occurs, it may
cause a physical impedance to water and electrolyte absorption through the colonic
enterocytes and hence contribute to diarrhea (88, 89) (Fig. 4).
In Vitro Models
Cellular attachment by B. pilosicoli strains has been studied in vitro using intestinal
epithelial cell lines, but to date no specific adhesins or host cell receptors have been
identified (111, 113). In infected Caco-2 cell monolayers, the cell junctions were the
initial target sites for attachment (111). Subsequently the monolayers underwent a
series of changes, consisting of an accumulation of actin at the cell junctions, a loss of
integrity of tight junctions, and evidence for apoptosis occurring in the cells to which
the spirochetes were attached. As assessed by quantitative reverse transcription-PCR,
the colonized monolayers showed a significant upregulation of expression of inter-
leukin-1 (IL-1) and IL-8; in vivo these molecules may be responsible for attracting
neutrophils to the infected colon and enhancing inflammation. Candidates that might
cause cellular damage in vivo include the biological activities of LOS and/or of mem-
brane proteases (107, 108, 111). Exposure of the monolayers to B. pilosicoli sonicates
(containing LOS) caused a significant upregulation of IL-1, tumor necrosis factor alpha
(TNF-), and IL-6, while culture supernatants and sonicates from the nonpathogenic
Brachyspira innocens did not alter the expression of cytokines.
When B. pilosicoli cells were exposure to the stress hormone norepinephrine in vitro,
they showed enhanced growth rates, increased attraction to mucin, and more cells
attached to exposed Caco-2 cells (114). Norepinephrine may be present in the intestinal
tract following periods of stress, so it is likely that this stimulation of the spirochete also
can occur in vivo. Consequently, strains of B. pilosicoli may be more likely to cause
disease in individuals who are experiencing stress; this may include the stress in pigs
and chickens induced by intensive housing and similar stresses in people living under
crowed and poor socioeconomic conditions or having concurrent disease.
FIG 3 Scanning electron microscope image of B. pilosicoli cells attached by one cell end to a monolayer
of cultured Caco-2 cells.
Hampson Clinical Microbiology Reviews
January 2018 Volume 31 Issue 1 e00087-17 cmr.asm.org 10
 on D
ecem























Observations in Natural and Experimental Infections
Lesions seen in tissue samples obtained from individuals colonized by B. pilosicoli
under natural and experimental conditions also may be used to provide clues to the
pathogenesis of infection with the spirochete.
Gross appearance at necropsy or by endoscopy. In experimentally infected pigs,
gross alterations of the large intestines may be subtle, even in situations where the
colonic mucosa shows microscopic evidence of severe spirochetal infection (115). In
naturally infected pigs, the cecum and colon may be flaccid and fluid filled, with an
edematous serosal surface and enlarged mesenteric and colonic lymph nodes. The
large intestinal contents are usually watery, green to yellow, and frothy. Mild conges-
tion and hyperemia of the mucosa may be observed, with some necrotic foci and
erosions occurring (Fig. 5). Similar changes, including erosions in severe cases, may be
seen in the ceca of adult chickens naturally infected with B. pilosicoli (Fig. 6). In chronic
cases and in resolving lesions, hemorrhages may be covered by adherent fibrin,
necrotic material, and digesta. In adult chickens, sometimes few if any gross lesions may
be found in the large intestine, although the contents are often brown and frothy. In
humans with histologically diagnosed HIS, the endoscopic appearance of the mucosa
is commonly reported as normal, although there are other cases where the mucosa has
been edematous, and erythematous spots or erosions have been present (reviewed in
FIG 4 Scanning electron microscope image of dense fields of B. pilosicoli cells attached by one cell end
to the luminal surface of the colon in an experimentally infected pig.
FIG 5 Appearance of the luminal surface of the opened colon of a pig experimentally infected with B.
pilosicoli. The exposed mucosa shows congestion and hyperemia, with focal areas of superficial mucosal
erosions and hemorrhages tracking along the length of the colon.
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references 94, 116, and 117), including in a case where it was confirmed that B. pilosicoli
was the spirochete involved (118). Biopsy specimens showing HIS have been found at
sites throughout the colon and rectum, although a right-sided preference for positive
biopsy specimens has been noted (119).
A recent report from Japan found a significantly greater prevalence of HIS in
samples from patients with sessile serrated adenomas/polyps (SSA/Ps) than in samples
from control subjects, and a causal relationship was postulated (120). SSA/Ps are
advanced premalignant lesions that serve as the precursors of many cases of colorectal
cancer. A similar significant association was not found in Australian patients, although
it was suggested that this might reflect the methodology used or population differ-
ences (121).
Microscopic appearance in different species. Samples taken from experimentally
and naturally infected untreated animals are more likely to show advanced lesions than
are biopsy specimens taken from naturally infected humans, who would otherwise be
treated if they showed clinical signs. Microscopic lesions in pigs with PIS are generally
limited to the mucosa and submucosa but occasionally extend into the muscularis. The
mucosa may be thickened, edematous, and occasionally hyperemic, with dilated,
elongated crypts that are filled with mucus, cellular debris, and degenerate inflamma-
tory cells (neutrophilic exocytosis), and there may be a mixed infiltrate consisting of
neutrophils and lymphocytes in the lamina propria. B. pilosicoli cells occasionally may
be seen invading through tight junctions between colonic enterocytes, within goblet
cells, and in the lamina propria (37, 122). In the later stages of infection, inflammation
may result in multifocal erosive, ulcerative, or mucoid colitis. The mucosa becomes
thickened, and local ecchymotic or petechial hemorrhages occur on the surface, with
the protozoan Balantidium coli occasionally being seen associated with the damaged
porcine colonic mucosa (112). The crypt cell mitotic rate may be increased, resulting in
immature, cuboidal, or squamous epithelium being present on the surface of the
mucosa between crypts, leading to a reduction of absorptive surface area. As men-
tioned above, although sometimes focal and not always detected, the surface of the
colonic enterocytes may be covered by a fringe of spirochetes attached end-on to form
the characteristic “false brush border” (123, 124). Where this occurs, the spirochetes
invaginate into the terminal web cytoplasm of individual colonocytes, with associated
effacement of microvilli and disruption of microfilaments (54). An increase in eosinophil
numbers in biopsy specimens has been reported in humans with HIS, although the
species of spirochetes involved in the different cases was not identified (90). These
patients also had an increased risk of having irritable bowel syndrome. In pigs,
FIG 6 Appearance of the luminal surface of an opened cecum of an adult laying chicken infected with B. pilosicoli.
The exposed mucosa is covered by mucoid tan content. Areas of congestion, focal erosions, and hemorrhage can
be seen in the mucosa underneath the contents.
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spirochetes also have been observed invading between epithelial cells in the extrusion
zone that is located between adjacent crypt units (37). In chickens, the cytoplasm of
enterocytes may appear damaged, with vacuolation, condensation, and fragmentation
of the chromatin (59). In an immunocompetent heterosexual man with histological HIS,
electron microscopy identified stunting of the microvilli together with spirochetes
invading colonic epithelial cells, goblet cells, macrophages, and Schwann cells (125). In
another patient, who had Crohn’s disease and ankylosing spondylitis, spirochetes were
found on the luminal surface of absorptive and goblet cells but also within the
cytoplasm, in occasional macrophages within the lamina propria, and again within the
occasional Schwann cell (126). Potentially, interference with Schwann cell function
could influence neuronal myelation and function at the level of the gut wall or in other
regions where the spirochete might invade. Interestingly, other spirochetes, including
Treponema pallidum, Leptospira species, and some Borrelia species, also may show
trophism toward neuronal tissue. In another study, spirochetal invasion was observed
in two HIV patients where there was an extension of IS into the crypts of Lieberkühn,
with spirochetal invasion of the colonic mucosa, and a marked inflammatory response
that involved macrophages in the underlying lamina propria (127). Spirochetes that are
presumed to have been B. pilosicoli also have been observed in the livers of immuno-
compromised human patients who had invasive colitis (128). There also has been a
report of aborted fetuses from young women showing nontreponemal spirochetes in
the lumen and mucosa of the intestine, as well as, less commonly, in other organs (129).
There is a possibility that these spirochetes were invasive B. pilosicoli.
Spirochetemia. Clear evidence for the invasive potential of strains of B. pilosicoli has
come from reports of the spirochete being recovered from the bloodstream of elderly
or critically ill humans with various immunosuppressive conditions (95–101). It is
interesting that other spirochetal diseases, including those caused by Leptospira species
and Borrelia species, have a spirochetemia as a central part of their pathogenesis.
B. pilosicoli has been demonstrated to attach to and agglutinate avian erythrocytes
in vitro, and if this clumping of red cells occurs in the circulation, it might contribute to
the severity of disease (130). Interestingly, relapsing fever Borrelia species also attach to
and agglutinate erythrocytes, forming rosettes. B. pilosicoli spirochetemia has not yet
been reported in naturally infected animals or birds, but this could reflect the fact that
blood cultures are rarely taken from species other than humans, and the slow-growing
anaerobic spirochete has specialized requirements for growth. In an experimental pig
that received cyclophosphamide to suppress its immune system and then was injected
intravenously with a B. pilosicoli culture, the spirochete was cultured from pericardial
fluid after 5 days, thus confirming that it is able to survive for long periods at
extraintestinal sites (131). Furthermore, in a group of 10 chickens experimentally
inoculated orally with a B. pilosicoli strain isolated from a chicken, the spirochete was
isolated from the livers of two chickens, and both had moderate to severe hepatic
lipidosis. Lymphoid hyperplasia with proliferation of ellipsoid macrophages and ger-
minal centers and the presence of pyknotic and karyorrhectic debris also was observed
in the spleens of the birds (83). In a subsequent experiment, B. pilosicoli again was
identified in the livers and spleens of chickens that were infected by the oral route
(132).
Experimental Infection of Animals with Strains of B. pilosicoli Isolated from
Humans
Evidence supporting the likely zoonotic potential of B. pilosicoli has come from
studies in which strains of B. pilosicoli that were isolated from humans (and sometimes
also from other species) were used to experimentally infect pigs (112), day-old chicks
(58–61), laying chickens (133), or mice (134, 135). Typically, colonization and disease
outcomes in these animals have been similar regardless of the species of origin of the
isolates.
Pigs. B. pilosicoli strain WesB, originally isolated from an Aboriginal child with
diarrhea, was used to experimentally infect young newly weaned pigs (112). A control
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group was infected with B. pilosicoli strain 95/1000, originally isolated from a pig with
PIS. Within 2 to 11 days, four pigs challenged with 95/1000 and two challenged with
WesB became colonized and developed watery, mucoid diarrhea. The affected pigs had
a moderate subacute mucosal colitis and had gross and histological changes similar to
those reported in pigs with either natural or experimental PIS. Spirochetes were present
within dilated intestinal crypts, and there was neutrophilic exocytosis and an increased
secretion of mucus. In one pig, large numbers of spirochetes were observed attached
to the colonic epithelium by one cell end. This study confirmed that human B. pilosicoli
strain WesB had pathogenic potential in pigs.
Chickens. In studies using newly hatched broiler chicks that were experimentally
infected with isolates of B. pilosicoli recovered from humans, pigs, and/or dogs, either
clinical signs were not observed (58) or the chicks developed watery diarrhea (59–62),
sometimes with a depressed growth rate (59). Gross cecal lesions were not seen, but
there were variable histological changes, including the characteristic occurrence of a
dense mat of spirochetes attached to cecal enterocytes by one cell end (59–61),
sometimes with a diffuse thickening of the cecal epithelial brush border (60). There was
variable crypt elongation, with dilation of crypt lumina and a mild focal infiltration
of heterophils (avian neutrophils) in the lamina propria. Sometimes spirochetes
were found between enterocytes or producing gap-like lesions, and subepithelial
accumulation of spirochetes and focal erosions without an inflammatory reaction
were recorded (58). Vacuolation and protein deposition were found in the apical
cytoplasm of some luminal enterocytes. In some cases, microvilli were obscured,
damaged, or obliterated by large numbers of attached spirochetes, and there was
disruption to the terminal web microfilaments. Individual spirochetes invaginated
into the cellular membrane and indented into the terminal web cytoplasm but did
not penetrate it (60).
The use of a human isolate of B. pilosicoli to experimental infect adult laying hens
resulted in a persistent and significant increase in fecal water content (133). In this case,
neither attachment of spirochetes nor gross pathological changes were found.
Mice. Isolates of B. pilosicoli of human, avian, or porcine origin were used to
experimentally infect lipopolysaccharide (LPS)-responsive C3H/HeOuJ [lps(n)/lps(n)]
and LPS-hyporesponsive C3H/HeJ [lps(d)/lps(d)] mice via gastric intubation (135). Cecal
tissue from mice infected with avian or porcine isolates revealed spirochetes attached
end-on to the apical surface of enterocytes, but this was not found with the human
isolate. There were no apparent differences in severity of cecal lesions between the two
mouse strains infected with these isolates. Transmission electron microscopy showed
spirochetes invaginated into the host cell membranes with a resultant effacement of
microvilli and loss of the glycocalyx.
In another experiment, weanling C3H/HeJ mice fed on standard or experimental
diets were inoculated with human strain WesB (134). The mice became colonized, but
no end-on spirochetal attachment to the epithelial cells of the cecum was observed.
Colonization was not associated with clinical signs.
Immunity
Host immune mechanisms directed against B. pilosicoli are poorly understood.
Agglutinating serum antibodies have been recorded in pigs that have recovered from
experimental infection (1), although no significant antibody levels against whole-cell
preparations of B. pilosicoli were found in experimentally infected pigs with mild colitis
18 days after exposure (136). In other experiments, pigs developed low levels of serum
IgG against B. pilosicoli whole-cell extracts after challenge (137). Mice experimentally
infected with B. pilosicoli strains also developed serum antibody responses to the
isolates (134, 135).
The existence of long-term colonization, involving intimate contact with the colonic
epithelium, suggests that the spirochete may be able to subvert or evade immune
mechanisms. If protection does occur, it may be strain specific, as B. pilosicoli strains
show considerable antigenic variability in their surface LOS (51). Nothing is known
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about passive maternal immunity, although it may occur, as natural infection with B.
pilosicoli has not been recorded in young chicks, piglets, or babies.
EPIDEMIOLOGY
Natural Habitat and Survival
Brachyspira pilosicoli colonizes the large intestines of many species of wild and
domesticated birds and animals. It is regarded as a common pathogen of pigs and adult
chickens, and on some farms infections with B. pilosicoli may be endemic. Cross-species
transmission undoubtedly occurs, and zoonotic transmission is highly likely, although
it has not been conclusively demonstrated (138). The spirochete is passed in feces, and
it may survive for prolonged periods in natural water systems such as lakes and ponds,
from which it can be isolated. These sorts of water bodies may contain nutrients and
anaerobic sludge that would favor the spirochete’s survival. For example, B. pilosicoli
has been shown to remain viable in lake water held at 4°C for 66 days or at 25°C for 4
days (29). It can survive for 119 days in soil and for 210 days both in soil containing 10%
pig feces and in pig feces alone (139). On the other hand, three different cell concen-
trations of B. pilosicoli survived in chicken cecal feces at 37°C for only between 2 and
17 h, with a maximum survival time of 72 to 84 h at 4°C (140). Chicken feces are acidic
and often dry, and this may account for the relatively short survival time of B. pilosicoli
in chicken sheds.
Dietary Influences on Colonization and Disease
As B. pilosicoli colonizes the large intestine, some aspects of the epidemiology of this
species may be influenced by the diet consumed, as this influences the microbiota and
physical and chemical conditions where colonization occurs. Analysis of risk factors on
Danish pig farms showed that the use of home-mixed and/or nonpelleted meal diets
was correlated with a reduced occurrence of PIS (141), while in experimentally infected
pigs, feeding them a pelleted diet increased the risk of colonization compared with
feeding meal (142). Under experimental conditions, the addition of carboxy methylcel-
lulose to a pig diet both increased the viscosity of the intestinal contents and encour-
aged colonization with B. pilosicoli following experimental inoculation (143). Grains
such as barley and rye have high levels of soluble nonstarch polysaccharide (“soluble
fiber”), which also may increase the viscosity of the colonic contents, and therefore
enhance the capacity of B. pilosicoli to colonize. Consistent with this, experimentally
inoculated pigs that were fed diets where the main cereal source was cooked white
rice, which is highly digestible and low in soluble fiber, showed less colonization with
B. pilosicoli than control pigs fed on a standard wheat-based diet (136, 143). On the
other hand, addition of insoluble fiber in the form of “distillers dried grains with
solubles” to a standard North American pig diet (based mainly on corn and soybean
meal) did not alter susceptibility to experimental infection with B. pilosicoli (144). There
is some evidence that dietary influences on colonization may occur in species other
than pigs. For example, in mice experimentally infected with a human strain of B.
pilosicoli (WesB), supplementing a standard mouse diet with lactose and zinc bacitracin
(ZnB) resulted in more animals becoming colonized, while supplementing just with zinc
bacitracin did not support colonization (134). Differences between typical human diets
consumed in developed and developing countries (and particularly in poorer villages
and peri-urban areas) potentially could contribute to the much high rates of coloniza-
tion in the latter settings.
Strain Typing Methods
As mentioned above, collections of B. pilosicoli isolates have been subjected to
subspecific differentiation using a variety of methods. All studies have demonstrated
the existence of extensive genetic heterogeneity in the species, and hence typing is
only really useful when trying to trace individual strains in situations where local
transmission is suspected. This approach can provide important epidemiological infor-
mation to help devise control measures. Where different strains are present in individ-
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uals in a village or in animals on a farm, they either may have been independently
introduced or may have arisen from “microevolution” of the original strains that were
present at that location (39).
Most recently, the advent of next-generation sequencing (NGS) has allowed inex-
pensive whole-genomic sequencing so that techniques such as multilocus sequence
typing now can be performed without the need to amplify and sequence individual
genes. At the same time, the genome potentially can be screened for other genes, such
as those predicted to be involved in virulence and/or antimicrobial susceptibility. To
date NGS has not used with large numbers of B. pilosicoli isolates, although it has been
applied to collections of B. hyodysenteriae isolates (145).
Pigs
PIS has been reported in most countries where pigs are reared. Investigations in
different regions have found that a high proportion of farms often may be infected
(146) and that infection is common in farms having pigs with persistent diarrhea
problems (141, 147, 148). Increased recognition of the condition has resulted from
improved diagnostic methods, the reduction in use of routine antimicrobial growth
promoters that may have been inhibiting growth of the spirochete (149, 150), and the
fact that other major intestinal diseases of pigs are now better controlled in many
countries.
Transmission is believed to occur by the fecal/oral route, and infection may be
introduced into naive herds by carrier pigs or by feral birds or animals that access the
farm (32, 151, 152). B. pilosicoli can persist in the environment, and the disease can recur
between batches of pigs if the premises are not adequately cleaned and disinfected. On
one pig farm, B. pilosicoli was found in chickens, effluent pond water, and wild ducks
visiting the effluent pond (151). An isolate recovered from the pond water had the
same genetic type as one from a pig. These findings emphasize that water should not
be recycled on piggeries and support previous suggestions that feral water birds may
contaminate water supplies and so present a potential source of B. pilosicoli infection
for pigs and for other animals (29).
The on-farm epidemiology of B. pilosicoli can vary considerably between farms (151).
Sometimes the incidence is low and largely confined to pigs of one age group, while
in other herds it may be widespread and associated with a number of different B.
pilosicoli strains. The latter occurrence on certain farms might explain why PIS com-
monly recurs in convalescent animals or in those treated with antimicrobials. In such
cases, reinfection may be with a different strain, possibly having different antigenic or
other biological properties.
Chickens
AIS is rarely diagnosed, as the clinical signs usually are relatively mild and nonspecific,
and most laboratories specializing in diseases of poultry do not regularly use diagnostic
methods suitable for detecting intestinal spirochetes. On the other hand, epidemiological
surveys have shown that infection is common in flocks of laying and breeding chickens in
Europe, Scandinavia, North and South America, Malaysia, and Australia (63–70). Besides
caged or housed flocks, outdoor free-range flocks and organic flocks with access to outside
areas are commonly affected (71, 72, 76). In most regional studies, approximately 70% of
laying flocks and 50% of breeding flocks contain chickens that are colonized by
Brachyspira species. Within-flock prevalence varies from 10% to 95% of the tested
samples. About 20% of these infected flocks contain chickens that are colonized with
B. pilosicoli (63, 65, 67), and flocks with diarrhea or poor egg production are colonized
more commonly than flocks with normal feces. Flocks with chickens that are over 40
weeks old are significantly more likely to be infected than flocks with younger chickens
on the same farms (63, 65, 67, 76), and multi-age farms have the highest risk of infection
(75). This pattern is likely to reflect relatively increased cumulated opportunities for
transmission of the spirochetes to chickens as they age.
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Prevalence based on colorectal biopsies. There are a number of reasons why it is
difficult to estimate the prevalence of B. pilosicoli infections in humans based on
examination of colorectal biopsy specimens. First, biopsy specimens are regularly taken
only from selected patients, and these include patients who may be suspected of
having HIS (e.g., chronic diarrhea, rectal bleeding, abdominal pain, and/or bloating) and
a much larger group of other patients with conditions such as suspected colonic
adenomas, inflammatory polyps, or inflammatory bowel disease. Second, even where
HIS may be present, not all cases are recognized by the histopathologist. Third, biopsy
specimens are regularly taken only in facilities in developed countries, meaning that
there is little information from much of the world. Fourth, even when HIS is observed,
the majority of studies have not attempted to differentiate between B. aalborgi and B.
pilosicoli as the etiological agent. Lastly, while there are numerous case reports where
intestinal spirochetes have been seen attached by one of their cell ends to enterocytes
in the colon and/or rectum, prompting a diagnosis of HIS, there are few control studies
from the general population.
Although people undergoing colorectal biopsies are representative of only a small
portion of the general population, in two studies where biopsy specimens from
colorectal resections were examined for evidence of HIS, prevalences of 2.5% and 3.0%
were found, in mid-Norway and South Norway, respectively (153, 154). This compares
with detection rates of 20 to 50% in rectal biopsy specimens taken from homosexual
males (155, 156) and 44% in biopsy specimens from HIV patients in other Western
countries (13).
Anaerobic culture on selective medium of rectal biopsy specimens from 22 male
homosexuals showing histological evidence of HIS resulted in the isolation of B.
pilosicoli from 50% of the samples (14). In comparison, where molecular techniques
have been used to identify the species of spirochetes present in HIS samples from the
general human population, these have shown that B. aalborgi is the most common
species involved (157). Examples from different studies include the following: 62.5% B.
aalborgi and 0% B. pilosicoli (158); 86% B. aalborgi and 14.3% B. pilosicoli (159); 70% B.
aalborgi and 6% B. pilosicoli (160); 100% B. pilosicoli and 0% B. aalborgi in 3 HIV
homosexual males, with 78% B. aalborgi and 19% B. pilosicoli in 31 HIV homosexual
males (161); 80% B. aalborgi, 14% B. pilosicoli, and 6% both species (162); 100% B.
aalborgi but 15% also B. pilosicoli (163); and 69% B. aalborgi, 30% B. pilosicoli, and 1%
both species (164). In some studies, other, atypical strains also were identified. Al-
though B. aalborgi is associated with many cases of HIS, the extent to which it can act
as a potential human pathogen remains unclear.
Prevalence determined by fecal carriage. A better understanding of B. pilosicoli
prevalence has come from studies where the spirochete has been identified in feces
specifically collected from different populations for this purpose. Identification has
been by isolation from feces combined with PCR for species determination and/or by
direct PCR detection on DNA extracted from the feces. A striking feature of the reported
studies has been the high proportion of apparently “normal” individuals in developing
countries who are colonized by B. pilosicoli. These have included native populations in
Oman (26.7%, 11.4%) (10), India (25.6%) (165), Papua New Guinea (PNG) (22.8%) (104),
Rwanda (22.6%, 14%) (166), and the island of Bali in Indonesia (11.8%) (105). Carriage
also is common in rural Aboriginal Australians (32.6%) (11), among whom the standard
of living is often much lower than that for other Australians. In Bangladesh, large
numbers of intestinal spirochetes (presumed to be B. pilosicoli) were found in the feces
of over a third of patients with cholera (167). The high prevalence of B. pilosicoli among
individuals living in developing countries may be related to conditions such as in-
creased exposure as a result of poor hygiene, environmental factors such as the poor
quality of water supply and animal contact, host factors such as low immune status and
coinfections, and nutritional deficiencies or differences in dietary ingredients compared
to the case for more affluent Western populations (22, 104).
In contrast, infection with B. pilosicoli in the general population of developed
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countries appears to be uncommon. Of 1,679 Belgian patients with diarrhea, only 1.2%
carried a spirochete called Treponema hyodysenteriae by the authors (166) but which
was almost certainly B. pilosicoli. Similarly, spirochetes that later were identified as B.
pilosicoli were present in fewer than 0.9% of non-Aboriginal Australians, including in
656 adults and children recorded as having gastrointestinal disturbances and in 39
healthy children (11, 22). In subsequent studies in Western Australia, B. pilosicoli was
isolated from the feces of 10% of 151 rural Aboriginal patients with gastrointestinal
complaints but from none of 142 non-Aboriginal rural patients with similar conditions
(168). In a later study using PCR detection, B. pilosicoli was identified in the feces of
14.5% of rural Aborigines with gastrointestinal disorders but not in any non-Aboriginal
patients or healthy individuals (169). Infection with B. pilosicoli in Aboriginal patients
was significantly associated with having chronic diarrhea and with failure to thrive and
being underweight in children. In another study, among 586 non-Aboriginal individuals
who were long-term residents of Perth, Western Australia, including elderly patients in
care or in hospital, children, and individuals with gastrointestinal disease, only one
(elderly) person with a history of diverticulitis was culture positive for B. pilosicoli (170).
Studies in Italy have successfully isolated B. pilosicoli from the feces of patients with
gastrointestinal disease (7, 171), although their ethnicity, travel history, and background
were not described.
Immigrants and visitors to developed countries. In a large study in Great Britain
where feces were cultured, a 1.5% prevalence of spirochetes having the growth and
biochemical properties of B. pilosicoli was found. A striking feature was that the
colonized individuals all either were of Indian descent and had recently visited the
Indian subcontinent or were male homosexuals (8). The specific prevalences of carriage
in these two subpopulations were 4.8% and 20.6%, respectively.
In a study of healthy immigrants to Western Australia, carriage was detected in
10.6% of the population, with the prevalence being significantly higher among indi-
viduals from the Middle East and from Africa than among individuals from other
regions (170). In another study, a fecal carriage rate of 15% was found among 227
recent healthy immigrants to Australia (169). In the original study, feces from 17 of 180
(9.4%) Indonesians who either were short-term or medium-term visitors to Perth,
Western Australia, were found to be culture positive for B. pilosicoli (170). The colonized
individuals had lived in Perth for periods varying from 10 days to 4.5 years (with a
median duration of 5 months).
Persistence of infection. When the Indonesian visitors to Perth subsequently were
resampled at different times, all the people who had been culture negative remained
negative, and a few individuals who had been positive remained so after 5 months
(170). Pairs of isolates that were recovered from two individuals after 4 and 5 months
had the same pulsed-field gel electrophoresis (PFGE) types, while two isolates with
different PFGE types were recovered 2 months apart from the same individual. It was
suggested that culture-positive individuals were likely to have been either colonized
while in Indonesia or infected while in Perth, perhaps as a result of contact with other
colonized visiting Indonesians with whom they lived or socialized. There was no
significant association between colonization with B. pilosicoli and clinical signs when
the individuals were tested, but B. pilosicoli was 1.5 times (confidence interval, 0.55 to
4.6) more likely to be found in feces with a wet-clay consistency than in normal feces.
In a study in rural villagers in PNG where repeated samples were taken from
individuals at different times, the results indicated that every individual was likely to be
newly infected with a B. pilosicoli strain at least once a year, and on average, individuals
were colonized for 4 months per year (104). Numerous different B. pilosicoli strains
circulate in these environments, and mixed infections with different strains probably
were common (28). The weight of infection was very high and may have impacted the
vitality of the whole community.
Homosexuality and/or HIV status. Infection with B. pilosicoli occurs at an increased
frequency in males who have sex with males and in HIV patients. For example, B.
pilosicoli was isolated from half of the rectal biopsy specimens obtained from homo-
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sexual males who were visiting a clinic for sexually transmitted diseases in Sydney,
Australia (14), most of whom had nonspecific gastrointestinal symptoms and about half
of whom were HIV. Other studies have associated HIV status and an increased
frequency of colonization with B. pilosicoli (155, 156). A number of case reports on fecal
carriage of intestinal spirochetes have described isolation of spirochetes from homo-
sexual males (5, 9, 172).
Age. In a number of studies B. pilosicoli has been shown to be more prevalent in
children than in adults. For example, Australian Aboriginal children who were aged
between 2 and 18 years were significantly more likely to be colonized with B. pilosicoli
than were children who were less than 2 years old or than were adults (11). In another
study, carriage of B. pilosicoli again was significantly increased in 2- to 5-year-old
Aboriginal children compared to older individuals (168). Similarly, colonized hospital-
ized Omani patients were more likely to be older than 2 years than younger (10). On the
other hand, studies in both Bali and India found that carriage of B. pilosicoli was not
associated with the age of the participants (105, 165). A review of the recent literature
on HIS in children has been published (87).
Gender. Most studies of B. pilosicoli carriage in heterosexual individuals have failed
to record the gender of the individuals involved. In a study in PNG, no difference in
carriage rate associated with gender was found (44), although studies of HIS in Norway
found that the condition occurred more commonly in males than in females (153, 154).
Transmission between humans. There are no reports of specific studies investigat-
ing transmission of human intestinal spirochetes, although the studies on fecal carriage
have allowed analysis of environmental factors that may be important in transmission.
It is presumed that infection occurs in humans via the oral route, following exposure to
infected fecal material, in the same way as for animals (104). In PNG, colonization with
B. pilosicoli was significantly more common in individuals living in villages than in those
living in an urban area. Hygiene in the villages was poor, as modern sanitation and
running water supplies were not available, and nearby streams were the only source of
water (104). In Bali, the highest rate of colonization with B. pilosicoli occurred in a
peri-urban area rather than in rural villages (105). This peri-urban area was crowded and
contained pigs and other animal species, and the people obtained their water from
shallow wells rather than having a supply of clean tap water from the city supplies. In
India, B. pilosicoli was significantly more common in individuals who obtained their
drinking water from a well or if their water was treated before use because of its poor
quality (165). Taken together with the fact that B. pilosicoli may survive for long periods
in water (29), these studies suggest that contaminated water sources may help to
account for the high rates of intestinal carriage with B. pilosicoli found in developing
communities.
Opportunities for cross-species transmission. B. pilosicoli colonizes a wide range of
hosts, and in households where animals and humans live in close proximity, there is
potential for zoonotic transmission. Similarly, individuals working with intensively
farmed pigs, chickens, or other farmed species may be at increased risk of exposure.
The spirochete has been isolated from waterbird feces on the ground and from pond
and lake water at picnic sites, including in a municipal zoological garden (29), as well
as from the feces of puppies for sale in pet shops (34). These occurrences demonstrate
the potential for transmission from animals to members of the general human com-
munity, and particularly to children. In one study, restriction enzyme analysis of B.
pilosicoli strains from dogs and humans indicated that some of these strains were
closely related (228). In another study, a B. pilosicoli isolate from an Australian dog and
isolates recovered from Aboriginal children in the same community were found to be
similar (22), again suggesting that dogs could be a reservoir for B. pilosicoli infections
in humans. In PNG, among the village animals sampled, B. pilosicoli was detected only
in four dogs and a duck and not in free-ranging village pigs (104). PFGE showed that
a canine isolate from one PNG village was the same as an isolate from a human from
another village, but no evidence was obtained to show that there could have been
direct cross-species transmission. In a survey involving 101 dogs sampled in three tea
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estates in India, only one canine isolate of B. pilosicoli was obtained (166), and hence
ownership of dogs did not represent a risk factor for carriage of B. pilosicoli by humans.
In all three studies discussed above, the lower prevalence of B. pilosicoli in dogs than
in humans indicates that it is unlikely that dogs serve as a major source of human
infection in endemically infected populations, and indeed humans may act as a source
of infection for village dogs in situations where they engage in coprophagy of human
feces. In these environments, infection in humans seems more likely to come from
other infected individuals or from contaminated water sources. B. pilosicoli also has
been found on the carcasses of “spent” laying hens (hens discarded because they have
stopped laying) in a supermarket in Belgium, and this may represent a potential source
of transmission to humans who handle or consume this material but also to dogs that
may be fed on raw chicken carcasses (173).
A summary of risk factors for human infection is presented in Table 2.
DIAGNOSIS
Clinical Signs
Clinical examination of individual pigs, chickens, and other animals, or groups of
these animals, may reveal signs such as poor or uneven growth, wet feces, and
species-specific effects such as delayed egg production that lead to a suspicion of
infection. It is important to examine a cross-section of affected individuals, if these are
available. In human beings, the occurrence of chronic diarrhea, failure to thrive in
children, and/or other nonspecific intestinal symptoms, particularly in population
groups that are known to be at increased risk, should prompt consideration of possible
infection with B. pilosicoli. A definitive diagnosis requires the demonstration of B.
pilosicoli, but the significance of this finding needs to be interpreted in the context of
a complete diagnostic investigation.
Diagnostic Samples
In the case of production animal species, postmortem examination of several
affected individuals should be undertaken if possible. The preferred diagnostic samples
from all species include fresh feces and/or a series of samples of the colonic wall/biopsy
specimens. In humans, endoscopy can be undertaken to look for suspicious areas that
than can undergo biopsy and subsequent histopathological and microbiological inves-
tigation.
Laboratory Diagnosis
Smears. Fecal or colonic contents or mucosal scrapings can be suspended and
either wet or dried smears prepared and examined for the presence of microorganisms
with the appearance of spirochetes. This simple screening approach is relatively
nonspecific and has limited diagnostic value in itself.
Culture. Brachyspira pilosicoli is anaerobic but will tolerate exposure to oxygen when
plates are opened on the bench. Due to its slow growth rate and tendency to become
overgrown by other, more rapidly growing species, selective solid medium systems are
TABLE 2 Factors associated with increased risk of human infection with B. pilosicoli
Risk factor
Contamination of drinking-water supply with human or animal feces
Bathing in contaminated water (lakes, ponds)
Living in rural or peri-urban villages in developing countries
Living in rural Australian Aboriginal communities
Recent migration or travel from a developing country
Crowding and poor socioeconomic environment
Male homosexuality (men having sex with men)
HIV status
Coinfection with B. aalborgi and/or intestinal protozoa
Contact with animals?
For spirochetemia, debilitation and immunosuppression
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used for primary isolation from feces or colonic samples (174, 175). Typically, the
medium consists of Trypticase soy agar supplemented with 5 to 10% defibrinated ovine
or bovine blood, together with 1 to 5 antibiotics (including spectinomycin, rifampin,
spiramycin, vancomycin, polymyxin, and/or colistin) to make the medium selective. A
frequently used isolation plate contains 400 g/ml spectinomycin and 25 g/ml each
of colistin and vancomycin (174). Alternatively, spectinomycin (400 g/ml) can be used
or can be used in combination with polymyxin B (5 g/ml). Plates can be incubated in
an anaerobic jar (with 94% H2 and 6% CO2) or anaerobic chamber (with 80% N2, 10%
H2, and 10% CO2). Incubation can be at 37°C, but enhanced growth and selection occur
at 41°C. Plates should be examined after 3 days and reexamined every 2 to 3 days for
up to 2 weeks. The spirochetes form a low flat sheen of confluent growth with sharply
defined edges. Growth sometimes penetrates the agar and is surrounded by weak
hemolysis. Colonies generally are not formed, but some may occur on fastidious
anaerobe agar after prolonged incubation. Growth can be confirmed by the charac-
teristic morphology and motility of the spirochetes on wet mounts using dark-field or
phase-contrast microscopy. Subcultures can be made on nonselective blood agar
plates. The lack of colony formation and the potential presence of other Brachyspira
species means that it is preferable to undertake repeated rounds of subculturing to
obtain a pure culture before proceeding with other tests.
Secondary culture. The spirochetes can be further propagated in anaerobic brain
heart infusion broth supplemented with 10% fetal bovine serum incubated at 37 to
41°C. Growth has been shown to be enhanced by adding 1% oxygen to the N2
environment and by shaking the culture vigorously (176). The oxygen is consumed by
NADH oxidase activity, while shaking presumably increases the gas/liquid interface and
may replicate conditions occurring in the colon. The same physical conditions can be
used to enhance growth in Kunkle’s medium, a prereduced anaerobic Trypticase soy
broth medium containing 2% fetal bovine serum and cholesterol (177). Under optimal
conditions, growth of 108 to 109 cells per ml can be obtained in either of these broths
within 2 to 3 days.
Blood cultures. If spirochetemia is suspected, a series of blood samples should be
taken and incubated in anaerobic blood culture bottles incorporating suitable detec-
tion methods. B. pilosicoli can be detected using some manual blood culture systems,
with an incubation period of up to 10 days followed by subculture (38). The most
commonly described media in which the spirochete have been detected are the
Hémoline and BBL Septi-Chek formulations, although they have been detected in
automated systems after prolonged incubation of up to 15 days (38, 95–101). Growth
may not always be automatically signaled, and the medium should be visually checked
for turbidity and aliquots examined for spirochete cells using phase-contrast micros-
copy.
Storage. Isolated spirochetes can be stored at 80°C in 50% horse serum–1% brain
heart infusion broth–10% glycerol, under which conditions they will survive for 5 years
or more. B. pilosicoli also survives for extended periods at 80°C when cultures growing
in Kunkle’s broth are frozen directly.
Biochemical characteristics. Biochemical characterization of intestinal spirochetes is
no longer routinely undertaken in veterinary diagnostic laboratories. It was thought
that the capacity to hydrolyze hippurate could be used to differentiate B. pilosicoli from
other weakly hemolytic intestinal spirochete species, but that test is now considered
less reliable as hippurate-negative isolates have been described (54).
MALDI-TOF MS. In recent years, matrix-assisted laser desorption ionization–time of
flight mass spectrometry (MALDI-TOF MS) has been adapted for rapid and inexpensive
identification of isolates of Brachyspira species, including B. pilosicoli. Identification is
based on the profile of spirochetal proteins, including ribosomal proteins and others
with housekeeping functions (178).
Antigen detection methods. Monoclonal antibodies (MAb) raised against cell
envelope proteins of B. pilosicoli have been described (179, 180), and these poten-
tially could be used in fluorescent or immunoperoxidase antibody tests on fecal
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smears or on histological specimens to identify this species (see “Immunohisto-
chemistry” below). Unfortunately, these reagents are not commercially available. A
MAb-based immunomagnetic separation of B. pilosicoli from feces prior to culture
and PCR did not improve the sensitivity of detection in pig feces compared to direct
culture and PCR (181).
PCR detection and identification. Diagnosis by culture is routinely supported by
the use of PCR tests for confirmation of the identity of isolates suspected to be B.
pilosicoli. Growth from the primary isolation plate is picked off using a sterile wire
or toothpick and added directly to the amplification mixture, or the spirochetes can
be subcultured to purity before being subjected to PCR amplification for identifi-
cation. In laboratories where appropriate culture methods are not available or
where a rapid diagnosis is required, DNA can be directly extracted from feces or
from colorectal biopsy specimens and used for PCR (157–159, 182, 183). PCRs also
have been used on spirochetes recovered by laser capture from fixed cecal mucosa
in infected turkeys (30).
The PCR targets that are most commonly used are the B. pilosicoli 16S rRNA gene,
which contains a signature sequence for this species (26, 184), but other PCRs based on
the 23S rRNA gene (185) and portions of the nox gene encoding NADH oxidase also
have been described (186). Also, amplification of portions of the nox gene followed
either by sequencing (186) or by restriction fragment length analysis of the product
(187) has been used to determine the species Brachyspira isolates in specialized
veterinary diagnostic laboratories.
Duplex and multiplex PCRs, detecting different Brachyspira species and sometimes
also detecting other enteric pathogens, and quantitative PCR assays that allow spiro-
chete quantitation also have been described for use in samples from pigs (188–192),
chickens (189, 193), and humans (194).
Biopsy Specimens and Colonic Mucosa
Histology. As indicated above, light and electron microscopic examination of
colorectal samples may detect spirochetes attached to the mucosa. Although the visual
detection of attached spirochetes is highly suggestive of an infection with B. pilosicoli,
in cases of HIS, the spirochetes involved also could be B. aalborgi. The attached
spirochetes are easier to visualize with silver-based stains than with hematoxylin and
eosin staining.
Although end-on attachment of B. pilosicoli to colonic enterocytes is a common
feature of the disease for all species, its occurrence may be localized, and it is not
observed in all colonized individuals, including those with clinical signs (122). Conse-
quently, failure to detect attached spirochetes in no way excludes the possibility that
B. pilosicoli is colonizing the large intestine. To improve prospects for diagnosis, it is
recommended that multiple biopsy specimens or samples be taken from throughout
the colon to look for localized areas of attachment (91).
Imprint cytology. A recent study has shown that imprint cytology of human colonic
biopsy specimens can reveal spirochetes (subsequently identified as B. pilosicoli by PCR)
that are not necessarily detected as a “false brush border” by histology (195).
Immunohistochemistry. The application of antiserum to Treponema pallidum or
Leptospira interrogans to histological sections can be used to assist with identifying the
presence of attached spirochetes (85, 117, 163, 196). An alternative novel approach has
been the use of in vivo confocal endomicroscopy on fresh tissue, with specific fluores-
cent staining used to identify areas of spirochete attachment (197).
In situ hybridization. Another adjunct to diagnosis is the use of a fluorescent in situ
hybridization technique which uses fluorescent oligonucleotide probes to visualize and
localize spirochetes associated with the mucosa in formalin-fixed tissues. This approach
has been used with colonic samples from animals (198, 199) and with colorectal biopsy
specimens and fecal material from humans (164, 200). It has been combined with DNA
extraction from samples, followed by PCR amplification of the 16S rRNA gene and DNA
sequencing to identity the spirochetes involved (164). The technique also has been
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modified so that visualized spirochetes are isolated by laser capture microdissection
before individual microcolonies are subjected to direct 16S rRNA gene PCR and DNA
sequencing (201). An advantage of these techniques is that they provide simultaneous
identification and localization of the spirochetes associated with the intestinal mucosa
(Fig. 7).
DNA extraction and PCR. As discussed above, fixed tissue (including archived
tissue samples) also can be used for DNA extraction and PCR to identify attached
spirochetes.
Serology
To date no reliable serological assays are available for detecting evidence of
exposure to B. pilosicoli. A study using a recombinant B. pilosicoli ClpX protein as an
enzyme-linked immunosorbent assay (ELISA) antigen gave cross-reactions with sera
from humans who had no known exposure to the spirochete (202). Antigens with
potential for use in serological assays have been identified but not have not been
thoroughly tested for specificity (179, 180, 203).
PREVENTION
Vaccines
No commercial vaccines are available for prevention of B. pilosicoli infections. In
pigs an autogenous bacterin induced systemic antibody titers, but the vaccinated
animals still became colonized and developed diarrhea after experimental chal-
lenge (136). In mice, experimental vaccines based on two recombinant oligo-
peptide-binding proteins generated both systemic and colonic IgG antibody re-
sponses. After experimental challenge, the vaccinated mice were colonized for
significantly fewer cumulative days, and in the case of one protein, fewer mice were
colonized than in the control group (204). Oligopeptide-binding proteins may have
potential for use as B. pilosicoli vaccine components; however, they require further
testing in mice and other animal species.
Methods To Avoid Transmission of Infection
It can be difficult to avoid the introduction of B. pilosicoli into pig herds or flocks
of chickens because of the presence of potential reservoir hosts such as wild birds
and rodents that may access farms. This is a particular problem in uncontained
outdoor production units. Similarly, humans living in rural villages in crowded
conditions and lacking adequate hygienic facilities are at increased risk of exposure
via the fecal-oral route. Provision of clean water that is not contaminated with the
spirochete (and other pathogens) is a major consideration for the development of
control measures.
In order to reduce transmission in endemically infected pig farms, in it is important
to limit mixing of pigs from different age groups and sources. Avoiding rapid changes
FIG 7 In situ hybridization with a labeled oligonucleotide probe specific to B. pilosicoli, showing localized
attachment of a fringe of fluorescing spirochete cells to the surface of colonocytes in an infected pig.
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of diet at different stages of production, limiting stressors, and implementing manage-
ment strategies that limit access to contaminated environments can reduce the impact
of the infection. Replacing continuous-flow systems where pigs of all ages are present
on a farm by “all-in/all-out” (batch) systems reduces the risk of perpetuating infection
within a herd (146). Modification to the diet composition and/or physical form to
reduce the viscosity of the intestinal contents or adding zinc oxide in the feed at 3
kg/ton may be helpful in limiting spirochete proliferation. In laying chickens, however,
when zinc bacitracin (ZnB) was added to the diet, it enhanced colonization with B.
pilosicoli following experimental infection (205). ZnB acts mainly on Gram-positive
bacteria, and it is likely to have caused changes to the microbiota that directly or
indirectly facilitated colonization by B. pilosicoli.
Disinfection. Although B. pilosicoli is susceptible to many common disinfectants, the
efficacy of some commercial products is reduced by the presence of organic matter
(206). When alkaline salts, chlorine from a chlorine release agent, glutaraldehyde,
hydrogen peroxide, iodine as an iodophor, and quaternary ammonium were tested,
only alkaline salts failed to inactivate two concentrations of B. pilosicoli in the presence
of organic matter in under a minute (139). Hence, cleaning and using disinfectants on




Antimicrobial susceptibility. There are limited data available about the in vitro
antimicrobial susceptibility of isolates of B. pilosicoli recovered from animals and
humans, and much of the published work that is described below is quite old. The
choice and availability of antimicrobials for use in animals are more limited than they
are for human beings. For example, there are very few antimicrobials registered for
treatment of chickens that lay eggs for human consumption, because of concerns
about antimicrobial residues occurring in eggs. Antimicrobial use is less of a concern for
breeder chickens where their eggs are not eaten by human beings. Furthermore, in
recent years some drugs that were previously effective against B. pilosicoli, such as
dimetridazole and carbadox, have been prohibited from use in production animal
species in many countries.
The antimicrobial susceptibility of B. pilosicoli isolates recovered from animals and
humans has been evaluated using an agar dilution method that is based on the Clinical
and Laboratory Standards Institute guidelines developed for testing the susceptibility
of anaerobic bacteria, as well as by using broth dilution testing as was originally
developed for B. hyodysenteriae (207). The susceptibility patterns of different isolates
vary, and hence it is recommended that isolates be tested for susceptibility prior to
selection of the drugs to be used for treatment.
B. pilosicoli has penicillin-binding proteins in its cell envelope (208), and strains
potentially are susceptible to penicillins, although resistance does occur. Alterations in
penicillin-binding proteins that might lead to resistance through reduced binding have
not been explored, and resistance to penicillins is attributed to the activity of a wide
array of different and novel group D beta-lactamases that are produced by different
strains of the species (209, 210). Resistances to macrolides, lincosamides, and/or
pleuromutilins occur in some strains and are attributed to mutational changes on the
binding sites on the 50S ribosomal subunit (211, 212). Interestingly, a recent metabo-
nomics study has shown that B. pilosicoli cells exposed to the pleuromutilin tiamulin
retained metabolic activity even at concentrations where they show significant growth
inhibition (213).
Pigs. Antimicrobials can be used either prophylactically or therapeutically to reduce
B. pilosicoli infection in pig herds. Groups of affected pigs can be treated by water or
feed medication, although parenteral treatment may be necessary for individual pigs
that are severely affected. The main antimicrobials used to treat PIS in different
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countries are tiamulin, valnemulin, carbadox, dimetridazole, and lincomycin (214–216),
although isolates that are resistant to one or more of these drugs occur.
Chickens. Only a few drugs that are effective are available for use in egg-laying
chickens, and the availability varies in different jurisdictions. Susceptibilities of isolates
from chickens are similar to those found with pigs (217, 218). Tiamulin and lincomycin
are the most commonly used antimicrobials for the control of AIS (64, 132, 219),
although to avoid toxicity, tiamulin should not be used in combination with the
commonly used ionophores such as monensin, salinomycin, or narasin. Effective long-
term control of AIS in breeding flocks may require regular treatments with courses of
antimicrobials, for example, given at 1- to 2-month intervals, together with thorough
housecleaning and implementation of strict biosecurity measures designed to prevent
spread of infection between houses.
Humans. Analysis of the susceptibility of a collection of 123 isolates of B. pilosicoli
from humans from a variety of different geographic origins found that they were
susceptible to ceftriaxone, chloramphenicol, meropenem, metronidazole, moxifloxacin,
and tetracycline but not to erythromycin or ciprofloxacin (220). Isolates exhibited
various resistance to amoxicillin and clindamycin depending on their origin. Suscepti-
bility to amoxicillin was restored by the presence of clavulanic acid, which suggests the
involvement of -lactamase in causing the resistance. Over half the isolates were
-lactamase positive as assessed using nitrocefin disks, and the positive samples had
increased amoxicillin resistance.
Treatment with inidazole (a nitroimidazole similar to metronidazole) removed B.
pilosicoli from 16 of 18 PNG villagers who were excreting the spirochete in their
feces (42). Based on the in vitro susceptibility data and on many previous reports of
successful treatment for HIS (although not all necessarily associated with B. pilosi-
coli), metronidazole has been recommended as the drug of choice for therapy (87,
94, 117, 221–223). Therapeutic doses of metronidazole used have varied from 500
to 1,000 mg/day for 10 to 14 days. The use of macrolide antibiotics with or without
metronidazole also has been suggested as being the best therapeutic choice for
children with HIS (87).
Other Potential Treatments
Lactobacillus spp. have been shown to have antagonistic activities against B.
pilosicoli in vitro (224). Cell extracts of two Lactobacillus strains were shown to
suppress motility and growth of B. pilosicoli in vitro and to significantly reduce
adherence and invasion of the spirochete in a three-dimensional avian cecal organ
culture model (225). Subsequently, colonization and signs of disease were reduced
when L. reuteri LM1 was added to drinking water of chickens approaching the start
of lay, prior to experimental infection with B. pilosicoli (226). Large-scale use of such
probiotic cultures as prophylactics may be justified in some flocks with persistent
AIS problems but also potentially could be used for prophylaxis or therapy in other
species, including in humans.
Methods To Exclude B. pilosicoli
B. pilosicoli has been eradicated from a 60-sow pig herd by treatment of all
animals with the antimicrobial tiamulin followed by relocation of the breeding herd,
thorough cleaning and disinfection of the original premises, and then returning the
adult animals to the farm (227). This protocol would be more difficult to follow in
larger herds, and the existence of reservoir hosts such as wild birds and rodents
presents an ongoing threat of reintroduction. Consequently, strict biosecurity
measures would be required to maintain freedom from infection. The same con-
siderations apply to poultry farms, where strict external biosecurity is required,
together with biosecurity between sheds that house laying or breeding hens of
different ages. In humans who have an increased risk of infection with B. pilosicoli
(Table 1), improving personal hygiene and avoiding exposure to contaminated
water or foodstuffs is recommended to reduce opportunities for infection and
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further transmission. Effective control also requires that health professionals have a
better understanding of the existence of the spirochete and its natural history and
that appropriate diagnostic techniques are available to detect it.
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